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YAP is a multifunctional adapter protein and transcriptional coactivator with several binding partners well
described in vitro and in cell culture. To explore in vivo requirements for YAP, we generated mice carrying a
targeted disruption of the Yap gene. Homozygosity for the Yaptm1Smil allele (Yap/) caused developmental
arrest around E8.5. Phenotypic characterization revealed a requirement for YAP in yolk sac vasculogenesis.
Yolk sac endothelial and erythrocyte precursors were specified as shown by histology, PECAM1 immunostain-
ing, and alpha globin expression. Nonetheless, development of an organized yolk sac vascular plexus failed in
Yap/ embryos. In striking contrast, vasculogenesis proceeded in both the allantois and the embryo proper.
Mutant embryos showed patterned gene expression domains along the anteroposterior neuraxis, midline, and
streak/tailbud. Despite this evidence of proper patterning and tissue specification, Yap/ embryos showed
developmental perturbations that included a notably shortened body axis, convoluted anterior neuroepithe-
lium, caudal dysgenesis, and failure of chorioallantoic fusion. These results reveal a vital requirement for YAP
in the developmental processes of yolk sac vasculogenesis, chorioallantoic attachment, and embryonic axis
elongation.
Yes-associated protein (YAP65; referred to as YAP through-
out) is a modular adapter protein first identified as a binding
partner for the product of the proto-oncogene c-Yes (57). YAP
contains multiple protein interaction domains, including a pro-
line-rich amino terminus, a 14-3-3 binding site (3), WW domains
(32, 57), SH3 binding motifs (12, 57), a coiled-coil, and a consen-
sus PDZ binding motif at the extreme COOH terminus (43).
YAP mRNA is broadly distributed, and expressed sequence tags
have been identified in cDNA libraries from many different spe-
cies and from many tissues, cell lines, and tumor samples. Al-
though the cellular and subcellular localization of the YAP pro-
tein has been less well characterized, it is expressed in multiple
cell types and can be localized to both cytoplasmic and nuclear
compartments (3, 26, 32, 45, 60, 64, 69). This broad distribution
and the modular structure of YAP together suggest multiple
cellular functions.
The identification of YAP-interacting proteins has provided
insight into potential roles for YAP in cell signaling within
both cytosol and nucleus. YAP cytosolic interactions may im-
pact cell signaling pathways by several possible mechanisms.
For example, YAP binds the SH3 domain of c-Yes (57) and
can also associate with cytoplasmic PDZ proteins via its
COOH terminus (43). Therefore, YAP may play a role in the
anchoring and/or targeting of c-Yes to position the kinase to
respond to specific extracellular cues or to phosphorylate spe-
cific cellular substrates. Cytosolic YAP also may modulate
growth factor receptor signaling. For example, YAP associates
with the inhibitory Smad7 to attenuate transforming growth
factor  signaling (14) and may affect signaling via the ErbB-4
receptor (32, 45). In the nucleus, YAP may function as a
coregulator, modulating the activity of several transcription
factors. In this manner, YAP interacts with RUNX family
members (64, 69), which impact hematopoiesis and osteogen-
esis, as well as TEAD family members (39, 60), which are
implicated in muscle cell and neural crest cell differentiation.
Furthermore, we recently found that the proline-rich amino
terminus of YAP associates in the nucleus with heterogeneous
nuclear ribonucleoprotein U (26), a protein involved in mRNA
processing and the control of gene expression. Finally, several
pieces of data argue that regulated localization of YAP may
impact apoptosis and cell cycle progression. Indeed, in the
nucleus the YAP WW domain associates directly with the p53
gene family members p73, p73, and p63 and enhances the
transcription of proapoptotic Bax and Mdm2 reporter con-
structs and endogenous Bax (55). In addition, phosphorylation
by Akt stimulates YAP interaction with cytosolic 14-3-3 and
attenuates p73-mediated apoptosis (55). YAP may also asso-
ciate with p53BP2 (12), a protein known to inhibit the activity
of the p53 tumor suppressor. Thus, YAP likely exists in cell
type- and compartment-specific protein complexes that define
its function throughout development and in the adult organ-
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ism, and yet specific in vivo requirements for YAP remain
undefined.
YAP shows significant similarity to the product of the re-
lated gene, Taz (30). With amino acid identity approaching
50%, YAP and TAZ may share common protein partners, and
yet distinctions have been described (8, 21, 25, 26, 30, 37, 47)
The extent to which these proteins show unique or overlapping
function in vivo remains unclear. Thus, the potential for re-
dundancy between these proteins emphasizes the probable
complexity of YAP function and highlights the need for un-
derstanding in vivo requirements for YAP.
Although an integrated view of YAP protein interactions
and function is lacking, the data suggest that YAP is an adap-
tor protein that modulates multiple signal transduction path-
ways in many cell types. These pathways have been explored in
biochemical assays and in cell culture model systems, but little
is known regarding YAP function in the intact organism. To
investigate in vivo requirements for YAP, we generated mice
carrying a targeted disruption in the Yap gene. The embryonic
lethal phenotype of homozygous mutant mice indicates that
YAP is essential for embryogenesis and that, in fundamental
developmental events, TAZ does not compensate for YAP.
These results demonstrate for the first time a critical role for
YAP in early embryonic development.
MATERIALS AND METHODS
Generation of the Yap tm1Smil allele. A 507-nucleotide (nt) probe generated by
PCR amplification from a mouse lung cDNA library (primer pair 5-AGTTTC
TGTCTCAGTTGGGACG-3 [nt 13 to 34 of accession X80508] and 5-CAT
GCTGTGGAGTGAGAGGCTC-3 [nt 520 to 500 of X80508]) was used to
screen a 129SvEv mouse genomic library packaged in Lambda Gem-ll with 13- to
15-kb inserts. Two of nine plaques subcloned into pBluescript SK (Stratagene)
and partially sequenced provided genomic DNA sequence for the Yap targeting
vector construct. The targeting vector 5 arm of homology was generated by using
a phage HindIII to mouse HindIII 1.3-kb fragment as genomic sequence up-
stream of the Yap coding sequence. The targeting vector 3 arm of homology was
generated by using a Yap exon 1 internal XhoI to phage XhoI 7.0-kb fragment
that encompassed Yap exon 2 and downstream sequence. Subcloning these into
HindIII and XhoI cloning sites of the pOSdupdel6142-SA vector (kindly
provided by the UNC Animal Models Core) generated the targeting vector
pOSdupdel6142-Yap65. The targeting vector replaces about 1 kb of genomic
sequence with a reverse orientation, floxed MC1-neo cassette, and appends a
PGK-TK cassette for negative selection.
Vector electroporation into 129SvEv embryonic stem (ES) cells and selection
with Geneticin and ganciclovir, followed by PCR screening and Southern blot
confirmation identified six ES cell clones with the targeted recombination event.
ES cells from two expanded clones were injected into C57BL/6J blastocysts to
generate chimeric founders. Founder males from each ES cell line were crossed
to C57BL/6J female mice to give Yaptm1Smil mice heterozygous for the targeted
allele that then were crossed to initiate Yaptm1Smil lines. We used allele nomen-
clature according to the guidelines established by the International Committee
on Standardized Genetic Nomenclature for Mice and as implemented by the
Mouse Genomic Nomenclature Committee. All ES cell work and generation of
chimeric animals was conducted in the UNC Animal Models Core Facility
according to well-established and approved protocols.
NCBI Build 33.1 of the mouse genome, released on 3 September 2004 (http:
//www.ncbi.nlm.nih.gov/mapview/map_search.cgi?taxid  10090), indicated a pu-
tative locus, loc434366, identified by the gene recognition program GNOMON
and in opposing orientation to the Yap gene that also is perturbed in this allele.
The possible existence of a transcribed gene at this locus is supported by in silico
identification of a promoter signal on that strand using promoter recognition com-
puter algorithms (09/01/2004, McPromoter, http://genes.mit.edu/McPromoter.html;
09/01/2004, www promoter scan, http://bimas.dcrt.nih.bov/cgi-bin/molbio/proscan;
09/01/2004, Promoter 2.0, http://www.cbs.dtu.dk/services/Promoter/output.php) and
by a single expressed sequence tag (accession CB600667) from the kidney cDNA
library 12886: NIH_MGC_176. If translated, this gene would produce a highly
unusual 95-amino-acid protein consisting largely of glutamic acid and lysine repeats.
Nonetheless, to assess the potential impact on our further studies of having also
disrupted this locus, we generated PCR primers in predicted loc434366 exons 2 and
3 (sequence below) and examined possible expression by reverse transcription-PCR
(RT-PCR). This primer pair generates a 433-nt amplicon from reverse-transcribed
RNA sequence but covers 3.2 kb of genomic sequence. We examined expression of
loc434366 in a mouse kidney cDNA library (Stratagene) and in wild-type embryos at
specific stages ranging from blastocyst (embryonic day 3.5 [E3.5]) stage to late
gestation (E18.5) and found expression in kidney but no detectable expression in
embryos until after E7.5 (data not shown).
Genotyping. ES cells, mice, and tissue scrapings from paraffin sections were
genotyped by either Southern blot or PCR-based methods. We generated a
542-nt Southern probe by PCR amplification from subcloned genomic sequences
5 to the Yap targeting construct using the primer pair 5-GCTGCCATTTCA
ACTTTCTAC-3 and 5-CAGCAGTCTATCGCTTTGTG-3. This probe rec-
ognizes an approximately 6-kb fragment from genomic DNA and an approxi-
mately 5-kb fragment from the targeted allele after enzymatic digestion with
BamHI. To genotype by PCR, we used a primer trio that included a shared 5
primer from sequence upstream of the Yap gene (YF, 5-GAAGCTGTGGCA
CAAAGA-3), a 3 primer in sequence deleted in the targeted allele (YR,
5-ATGCAAAGGCCACACTGT-3) and a 3 primer internal to the neo insert
(NR, 5-CGACGTTAACGGTACCAA-3).
Mouse colony maintenance. The transmitted Yaptm1Smil allele was maintained
on a mixed 129SvEv/C57BL/6J background. Crossing to an outbred (CD1;
Charles River) background to obtain larger litters for embryo analyses did not
perceptibly alter the phenotype of homozygous mutant embryos. Litters for
phenotype characterization were generated by natural matings and staged by
assigning the first half-day of embryonic development (E0.5) as noon the day of
vaginal plug observation.
RT-PCR. Gene expression was assessed in wild-type embryos from blastocyst
stage (E3.5) to late prenatal stage (E18.5) by RT-PCR. Positive controls for these
reactions were heart or kidney cDNA libraries (Stratagene). Whole-embryo total
RNA was extracted by using the TRIzol reagent (Invitrogen) according to the
manufacturer’s protocol with modifications for small tissue volume in embryos at
E10.5 as follows. (i) Embryos were dissected and rinsed several times in
ice-cold phosphate-buffered saline and then transferred with a minimal volume
to 40 l of TRIzol. (ii) Embryos were homogenized by pulling through a 22-
gauge 1 needle, and then the TRIzol volume was brought to 100 l. (iii) Finally,
after phase separation with the addition of 60 l of chloroform, RNA was
precipitated from the aqueous phase with 50 l of isopropanol. cDNAs were
generated according to manufacturer’s protocol with the reverse transcriptase
SuperScript II (Invitrogen). To test for expression of specific transcripts, we used
PCR primer pairs that spanned at least one intron as follows: Yap, 5-TCTGCG
CAGCCAGTTGCCTA-3 and 5-GCTCATGCTGAGGCCGCTGT-3; Yap2L
(32), 5-CCCTGATGATGTACCACTGCC-3 and 5-CCACTGTTAAGAAAG
GGATCGG-3; Taz, 5-TCCCCAACAACTCCAGAAGAC-3 and 5-CAAAGT
CCCGAGGTCACCAT-3; and loc434366, 5-GAATTGGAGTACAACTGGTTG
TGAACAG-3 and 5-ACCTAATTGTGGGTATCCTTTCATTTG-3.
In situ hybridization, immunohistochemistry, and histology. Whole-mount in
situ hybridizations on dissected E6.5 to E9.5 embryos were performed essentially
as described previously (61). Digoxigenin-labeled riboprobes were generated
using the sequence for Fgf8 (kindly provided by Gail Martin), Brachyury
(T, kindly provided by Bernhard Herrmann), and -globin (accession no.
BC037630, I.M.A.G.E. clone 497128; Open Biosystems) fragment for sense and
antisense probes subcloned into pBluescript II KS (Stratagene) using the PCR
primer pairs 5-AAACCATGGTGCTCTCTGGGGAAGA-3 and 5-TCTTGT
GTTTCTTCCTACTCAGGCTTTATTC-3 and Yap (mouse cDNA fragment
subcloned into pBluescript II SK) using PCR primer pairs 5-ACAGCCAGT
GGCGTTGTCTCTG-3 and 5-CGGAACTATTGGTTGTCATTGTTCTCA
ATTC-3.
Whole-mount immunohistochemistry for the PECAM1 antigen followed stan-
dard methods. Primary antibody against PECAM1 (Pharmingen) was followed
by horseradish peroxidase-conjugated goat anti-rat (mouse absorbed) secondary
antibody (Kirkegaard and Perry Laboratories) and visualized by using a nickel-
enhanced, peroxidase-based diaminobenzidine reaction.
Paraffin sections (8 to 12 m) of embryos in utero were hematoxylin and eosin
stained by using standard histological methods with fixation in 4% paraformal-
dehyde to allow subsequent genotyping by PCR from tissue scrapings of un-
stained sections of each embryo.
Protein expression analysis. Individual embryos obtained from intercross lit-
ters dissected at E8.5 and genotyped by PCR from a yolk sac tissue sample were
lysed in 20 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.1% sodium dodecyl sulfate,
1% Triton X-100, 1% deoxycholic acid, and 5 mM EDTA with a cocktail of
protease inhibitors. Lysates were cleared by centrifugation at 14,000  g for 20
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min at 4°C. Protein concentrations were determined by using the BCA assay kit
(Pierce Chemical Co.), and 20 g of embryo lysate was resolved by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis, transferred to polyvinylidene
difluoride membrane, and analyzed by Western blotting with anti-YAP 252. This
antibody was generated against the C-terminal portion of human YAP and
affinity purified (26). -Actin served as a loading control.
RESULTS
Although expression of both the Yap and the Taz genes has
been characterized in several cell lines and in Northern blots
for both human and mouse tissue (30, 32, 45, 60, 64, 69),
characterization of transcript distribution in whole tissue (39)
and throughout development is lacking. To begin to explore in
vivo roles for YAP, we examined expression of these genes in
mouse embryos.
Yap expression is widespread across mouse development;
Taz shows later onset. We examined developmental expression
of Yap and Taz by RT-PCR (Fig. 1) from blastocyst stage
(E3.5) to perinatal stages (E18.5). Yap expression was detected
at every stage examined. In addition, we examined the expres-
sion of a known mouse Yap splice variant in embryos from E7.5
to E18.5. Using the primer pair described previously (32), we
demonstrated the expression of two Yap transcripts both with
(Yap2L) and without the inclusion of the 48-nt (32) variant
exon 6 at all developmental stages examined (data not shown).
In contrast, we detected Taz expression at all later stages but
not in blastocyst stage embryos (Fig. 1). Thus, Yap and Taz
appear prevalent across mouse embryo development but show
differential expression at the earliest stages.
We further explored Yap expression by whole mount in situ
in wild-type mouse embryos from E6.5 to E8.5 (Fig. 2). Again,
we found widespread Yap expression overall, with dynamic
stage- and region-specific domains of higher relative expres-
sion. At E6.5 (Fig. 2A to D), we observed Yap expression
throughout extraembryonic ectoderm, epiblast, and nascent
mesoderm in early streak-stage embryos (Fig. 2A and B) but
found at later stages (Fig. 2C) more intense expression in and
adjacent to proximal epiblast regions. At E7.5 (Fig. 2E to G)
we found widespread Yap expression with region-specific in-
tensity distinctions (Fig. 2E and F). We observed strongest Yap
expression in extraembryonic mesoderm and also in a ring of
mid-proximodistal extraembryonic ectoderm. The strong ex-
traembryonic ectoderm expression domain was proximal to the
region forming the chorion. At this stage, Yap expression ap-
peared lowest in visceral and definitive endoderm. By E8.5
(Fig. 2H,I) Yap expression remained widespread, with a strong
expression domain at the distal tip of the allantois (Fig. 2H).
Overall, we observed a nearly ubiquitous, but dynamic, Yap
expression pattern that modulated within detectable levels
across developmental stages and distinct cell types.
Homozygous Yaptm1Smil mutation is embryonic lethal. To
define in vivo requirements for YAP, we developed a targeting
construct designed to disrupt Yap transcription. In the targeted
FIG. 1. Yap and Taz show widespread expression by RT-PCR
across a series of mouse embryo developmental stages. PCR amplifi-
cation of gene-specific products from cDNAs derived from mouse
embryo total RNA obtained at E3.5, E6.5, E7.5, E10.5, E12, E13.5,
E16.5, and E18.5 with () or without () RT. Yap expression was
found at all stages examined from E3.5 blastocyst to E18.5 perinatal, in
contrast to Taz expression, which was detected at all examined stages
except E3.5 blastocyst.
FIG. 2. Dynamic but broad Yap expression in wild-type mouse em-
bryos visualized by whole mount in situ hybridization. Yap mRNA is
broadly distributed in trophectoderm and epiblast derivatives from
E6.5 to E8.5 and yet shows stage- and region-specific domains of
relatively stronger expression. Control sense probes gave little back-
ground at any stage (D, G, and I). Embryos are shown with anterior to
the left when known and proximal to the top. (A to D) Embryos at
E6.5 showed expression in extraembryonic ectoderm (arrows in panels
A and B) with high levels of Yap expression in epiblast becoming
restricted toward proximal epiblast (above arrows in panel C) and
lowest expression levels in visceral endoderm (arrowheads in panels A
and B). (E to G) Embryos at E7.5 show highest expression in extraem-
bryonic mesoderm and in a mid proximodistal domain in a ring of
extraembryonic ectoderm (black arrows in panels E and F) that was
proximal to the region forming the chorion (white arrows in panels E
and F). Again, lowest expression levels were in visceral endoderm
(arrowheads in panels E and F). (H and I) A broad Yap expression
domain was found in embryos at E8.5 with highest expression in distal
tip allantois (arrowhead in panel H). Asterisks mark regions damaged
at dissection. Stage-specific scale bars, 50 m.
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allele Yaptm1Smil we replaced genomic sequence, including the
Yap gene transcriptional and translational start sites and all but
10 bp of exon 1 with a reverse orientation MC1-neo cassette
(Fig. 3A). Electroporated ES cells subjected to positive and
negative selection were screened by PCR, and homologous
recombination confirmed with a 5 external probe by Southern
transfer (Fig. 3B). Mice carrying the Yaptm1Smil allele were
established by blastocyst ES cell injection and germ line trans-
mission from chimeric founders.
Progeny from Yaptm1Smil heterozygous intercrosses were
genotyped with PCR primer sets that generated a 259-bp prod-
uct from the wild-type Yap allele and a 195-bp product from
the Yaptm1Smil allele. Genotype analysis of E8.5 embryos ob-
tained from a Yaptm1Smil heterozygous intercross (Fig. 3C)
demonstrates the presence of all three expected genotype
classes.
To assess the impact of the mutant allele on YAP protein
levels, we used affinity-purified polyclonal antibody generated
against carboxy-terminal human YAP (26) to probe for endog-
enous mouse YAP in whole-embryo lysates obtained at E8.5
from Yaptm1Smil intercrosses. We did not detect the 65-kDa
YAP protein in homozygous mutant (Yap/) embryos by
Western blot analysis (Fig. 3D).
From over 900 heterozygous intercross progeny genotyped
postnatally (Table 1), homozygous Yaptm1Smil mice were never
recovered. In contrast, heterozygous mice were viable, fertile, and
exhibited no overt abnormalities. To delimit the stage of embry-
onic lethality associated with homozygosity for Yaptm1Smil and to
characterize the impact of YAP absence on development, we
obtained embryos at several stages across the developmental
timeline. From E6.5 to E9.5, we found genotype ratios consistent
with the expected Mendelian distribution (Table 1, 102  2.46,
DF2). Although we genotyped two partially resorbed homozy-
gous mutant embryos at E10.5, no Yap/ embryos were recov-
ered at later stages of development.
Yap/ embryos are indistinguishable from wild type at
E6.5 but show a characteristic appearance by E8.5. Although
we found no distinguishing characteristics that correlated with
genotype in embryos examined at E6.5 (n  45 embryos; from
seven litters), we did observe morphological perturbations in
some mutant embryos by E7.5. By E8.5 and E9.5, however, we
observed a characteristic Yap/ embryo appearance (Fig. 4).
Compared to wild-type siblings (Fig. 4A) at E7.5, Yap/ em-
bryos showed morphological variability ranging from overtly
normal (Fig. 4B) to severely perturbed (Fig. 4C). Perturbations
observed at E7.5 included very small embryos, the presence of
a marked constriction at the embryonic-extraembryonic boundary
(see also Fig. 5A) or complete separation of the epiblast and the
extraembryonic ectoderm. We observed some morphological ab-
normalities in about half of the embryos analyzed at this stage.
Nonetheless, most E7.5 homozygous mutant embryos were gas-
trulating, and many had generated a proper amnion and chorion.
In embryos from Yaptm1Smil heterozygous intercrosses char-
acterized at E8.5 (Fig. 4D to G), we found Yap/ embryos
displayed a consistent and stereotyped morphology typified by
a strikingly short and wide body axis, a distinctive multiple
folding of the anterior epithelium, caudal dysgenesis, and fail-
ure of chorioallantoic attachment. Despite chorion develop-
ment and allantoic extension, Yap/ embryos recovered at
these and later stages showed no evidence for attachment of
allantois to chorion.
Among embryos recovered a E9.5 (Fig. 4H and I), Yap/
embryos showed failure of ventral closure and turning, a con-
voluted anterior neurepithelium, and a characteristic bulbous
allantois. In addition, by this stage Yap/ yolk sacs had a
distinctive rippled appearance.
Histological analysis indicates proper tissue type develop-
ment but also yolk sac vascular defects in Yap/ embryos. To
provide a better understanding of developmental progression
in Yap/ embryos, litters from heterozygous Yaptm1Smil inter-
crosses were fixed in utero and processed for paraffin section-
ing and standard hematoxylin and eosin staining (Fig. 5). Wild-
FIG. 3. Targeted disruption of the Yap gene. (A) The Yap genomic
locus was altered by using a targeting vector that replaced approximately
1 kb of genomic sequence including the Yap ATG start site (*) and most
of exon 1 with a floxed reverse orientation MC1-neo construct. The 3
PGK-tk cassette allowed negative selection. A 5 genomic probe (large
dark bar) that recognized 	6-kb native locus and 	5-kb targeted BamHI
fragments revealed proper ES cell targeting and allowed genotyping by
Southern transfer. A primer trio (small bars) with a shared 5 primer (YF)
and distinct 3 primers, one in a region deleted after targeting (YR) and
the other specific for MC1-neo sequence (NR) allowed PCR genotyping.
(B) Southern blot of ES cell DNA showing proper targeting of two ES cell
lines. (C) PCR genotype of E8.5 embryos showing wild type, heterozy-
gous, and homozygous mutant genotypes. (D) Western blot with affinity-
purified rabbit polyclonal antibody to C-terminal YAP protein on E8.5
whole embryo lyses, indicating undetectable levels of YAP in homozygous
mutant embryos.




Yap/ Yap/ Yap/ Total
E6.5–E9.5 59 98 52 226 (16)a
E10.5–E17.5 13 34 2 49b
Postnatal 172 318 0 490c
a Number of resorptions included in total.
b Resorptions not recorded.
c Not all male progeny were genotyped after n  490; the actual number
genotyped postnatally with no homozygous mutant recovery exceeds 900.
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type embryos sectioned at E7.5 had generated a chorion and
amnion, embryonic and yolk sac mesoderm, and an allantoic
bud (Fig. 5A). In addition, wild-type yolk sac mesoderm adja-
cent to yolk sac visceral endoderm showed cell morphology
and organization consistent with early blood island develop-
ment (Fig. 5B). Consistent with the morphology of dissected
embryos, Yap/ embryos sectioned at E7.5 (Fig. 5A and B) had
generated mesoderm but this tissue layer appeared disorganized
(Fig. 5B) relative to that of control embryos. The Yap/ embryo
shown in Fig. 5A and B demonstrated the constriction at the
embryonic-extraembryonic boundary (Fig. 5A).
We also compared stained sections from wild-type (Fig. 5C
to H) and Yap/ embryos (Fig. 5C to H) at E8.5. Both
wild-type and homozygous mutant embryos showed distinct
chorion, amnion, and neuroectoderm development (Fig. 5C,
C, D, and D). In wild-type embryos, the thickened epithelium
of the streak region extended posterior to the node (Fig. 5C).
In contrast, in Yap/ embryos, despite development of a mor-
phologically recognizable node (not shown), posterior regions
showed a thinner tissue layer overlying the mesoderm extend-
ing to the amnion-allantoic bud junction (Fig. 5C). This fail-
ure to maintain a posterior epiblast-like epithelium in the
streak region is consistent with the observed caudal dysgenesis.
In addition, anterior neurectoderm in homozygous mutant em-
bryos showed excessive folding, extending as a single tissue
layer into the amniotic cavity (Fig. 5D). Some Yap/ em-
bryos developed anterior somites (Fig. 5E) that looked much
like those of wild-type sibling embryos (Fig. 5E), and some
initiated heart development (Fig. 5F) to stages similar to that
of wild-type sibling embryos (Fig. 5F). Development of the
Yap/ allantois (Fig. 5G) was similar to that of control sib-
lings (Fig. 5G), including extension into the yolk sac cavity and
differential cell morphology along the allantoic proximodistal
axis. In contrast, we observed striking differences in the devel-
opment of the yolk sac mesoderm. Wild-type embryos showed
an easily distinguished ring of yolk sac cells organized into
blood islands with the concomitant distinctions between endo-
thelial and hematopoietic precursor cells (Fig. 5H). In Yap/
embryos, although yolk sac mesoderm cells were abundant,
well-defined blood island-like structures were rare and showed
less clear cell type distinctions (Fig. 5H).
Yolk sac but not allantoic or embryonic blood vessel forma-
tion fails in Yap/ embryos. We used marker analysis to
characterize the yolk sac vasculature defect revealed by our
histological analysis. The PECAM1 antigen is a marker for
endothelial precursor cells in yolk sac and mouse embryo by
E8.5 (1). By E8.5, wild-type and heterozygous embryos stained
with an antibody against PECAM1 (Fig. 6A to C) show a
well-formed yolk sac vascular plexus, as well as allantoic and
embryonic blood vessels. In sharp contrast, although Yap/
embryos showed cells immunopositive for PECAM1, these
cells entirely lacked organization into vessels in the yolk sac
(Fig. 6D). Instead, PECAM1-labeled cells appeared to be pro-
fusely distributed across most of the yolk sac in homozygous
mutant embryos. Conversely, the developing vasculature in the
Yap/ allantois appeared fairly normal (Fig. 6E). Although
abnormally positioned, blood vessels also were evident (Fig.
6F) in the Yap/ embryo proper. Thus, although the endo-
thelial cell component of the early vasculature appears to be
specified during Yap/ embryogenesis, in the yolk sac endo-
thelial cells fail to organize into vessels.
The yolk sac vasculature develops with the concomitant
specification and organization of both endothelial and hema-
topoietic precursor cells. Early development of distinct cell
FIG. 4. Morphological phenotype of Yaptm1Smil homozygous em-
bryos from E7.5 to E9.5. Wild-type (A, D, E, and H) and homozygous
mutant (B, C, F, G, and I) embryos from Yaptm1Smil heterozygous
intercross litters were analyzed by light microscopy for gross morpho-
logical defects. E7.5 and E8.5 embryos are with anterior to the left and
proximal to the top unless otherwise noted; E9.5 embryos are shown in
a left-lateral view. A comparison of wild-type (A) and homozygous
mutant embryos at E7.5 revealed variability in the mutant phenotype
ranging from overtly normal (B) to highly abnormal (C). At E8.5
compared to wild-type siblings (D and E), homozygous mutant em-
bryos showed excessive folding of the anterior epithelium (e) and
failure of chorioallantoic fusion despite elongation of the allantois (al).
In embryos viewed from left lateral (D and F) the normal distal point
(dp)—the bend point of the unturned body axis for both wild-type and
homozygous mutant embryos—is indicated for comparison and illus-
tration of caudal dysgenesis observed in mutant embryos. Comparison
from a dorsal view with anterior to the left, of wild-type (E) and
mutant (G) embryos clearly shows development of an abnormally short
and wide axis with YAP deficiency. By E9.5, compared to wild-type
siblings (H), homozygous mutant embryos (I) were much smaller and
showed a stereotyped morphology that included failure of ventral
closure and turning and thus retention of the distal point (dp) of
earlier stages, a bulbous unfused allantois (al), and a distinctly rippled
yolk sac (ys). Scale bars: 130 m (A to C), 325 m (D to G), and 400
m (H and I).
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FIG. 5. Wild-type and homozygous mutant Yaptm1Smil embryos sectioned in utero for histological analysis. Representative sections from
wild-type (A to H) and homozygous mutant (A to H) embryos stained with hematoxylin and eosin are shown. Unstained sections for each embryo
were genotyped by PCR. By E7.5 wild-type embryos (A and B) developed chorion (#), amnion (large arrowhead) and mesoderm including the
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types occurs in a ring of yolk sac tissue as organized structures
referred to as blood islands which later anastomose to generate
the yolk sac vascular plexus. Because our histological analysis
of Yap/ embryos showed a large number of disorganized
yolk sac mesoderm cells, we explored development specifically
of the hematopoietic component of the yolk sac vasculature by
using a riboprobe to detect alpha globin expression. Alpha
globin is expressed in erythrocyte precursors present in the
murine yolk sac by E7.5 (35) and is present in these erythro-
blasts of the yolk sac primitive plexus at E8.5 (Fig. 6H). Whole-
mount in situ analysis for alpha globin showed expression of
this erythroblast marker in cells of the Yap/ yolk sac (Fig. 6I
to K) but in a domain lacking the distinctive organization
normally observed. Thus, in Yap/ embryos, we observe spec-
ification of both components of the early yolk sac vascula-
ture—endothelia and erythroblasts—but see failure of these
cells to develop with the organization of a proper primitive
vascular plexus.
Markers for streak-tailbud, midline, and anteroposterior
patterning of the neuraxis are evident despite morphological
perturbation of the embryonic body axis in Yap/ embryos.
We used whole-mount in situ analyses of expression domains
for several marker genes to help define the extent of patterning
achieved in the Yap/ embryo proper (Fig. 7). We used two
markers, fibroblast growth factor 8 (Fgf8) and homeobox gene
expressed in ES cells (Hesx1) (22), to reveal the extent of an-
teroposterior pattern present in the convoluted neurectoderm
of Yap/ embryos by E9.5. By organogenesis stages, Fgf8
normally is expressed in neurectoderm in both an anterior
domain and at the midbrain-hindbrain boundary, in addition to
branchial arch, limb bud and tail bud domains (7). Consistent
with the restricted bands of expression observed in wild-type
embryos (Fig. 7A), we found that Fgf8 was present in Yap/
embryos (Fig. 7B and C) in one or two narrow stripes across
the folded neuroepithelium, indicating elements of proper AP
patterning. Similarly, Hesx1 marked the anterior-most neurepi-
thelium (22) in both wild-type and mutant embryos (data not
shown). In addition, the posterior tailbud domain showed
proper Fgf8 expression in Yap/ embryos (Fig. 7B and C).
Because the body axis of Yap/ embryos appears short and
wide (Fig. 4F and G), we used a midline marker to assess
mediolateral patterning (Fig. 7D to F). Brachyury (T) normally
is expressed in the primitive streak, in the tail bud, and in the
notochord precursor cells that are distributed along the mid-
line of the embryo (62). In Yap/ embryos (Fig. 7E and F) we
found T expression in the streak and the tailbud. Although a
T expression domain also demarcated a midline in Yap/
embryos, this domain appeared unusually wide and the
T-expressing cells were distributed in a discontinuous manner.
This pattern of T expression suggests that Yap/ embryos
initiate midline development, specifying notochord precursor
cells, but the unusual mediolateral spread and discontinuity of
the T domain suggests abnormalities in development along the
mediolateral axis, which is consistent with the abnormally wide
axis morphologically evident in mutant embryos (Fig. 4G).
DISCUSSION
Embryos lacking YAP arrest development around E8.5 and
display defects in yolk sac vascular development (Fig. 5H, 6D,
and H), chorioallantoic fusion (Fig. 4I), and embryonic axis
elongation (Fig. 4F, G, and I). The complexity of the mutant
embryo phenotype, with profound defects in both the embryo
proper and the extraembryonic regions, and the observed
widespread developmental Yap gene expression (Fig. 2) to-
gether support multiple roles for YAP in development. In
general, the source of failed embryonic progression in Yap/
embryos does not appear to result from primary problems with
tissue specification since histological (Fig. 5), and marker anal-
yses (Fig. 6 and 7) indicate relatively normal development of
distinct cell types in both the yolk sac and the embryo proper.
Instead, our results may reveal vital requirements for YAP in
morphogenetic movements or maintenance of proper cell
number during embryogenesis.
YAP is required for early steps in development of both yolk
sac vasculature and placenta. One striking outcome of analy-
ses of mouse mutant phenotypes in recent decades has been
the understanding that, although profound developmental dis-
turbances in the embryo proper may be tolerated until late
gestational stages or even to birth, disruption in the cardiovas-
cular and placental systems likely results in death in utero (4, 5,
50). Consistent with this observation, Yap/ embryos, which
die in the first half of gestation, show significant perturbation
in early yolk sac vascular development, as well as in an early
step in placental development. Current understanding of vas-
cular development in the yolk sac suggests a multistep progres-
sion initiating with vasculogenesis (11). Although the molecu-
lar regulation of vasculogenesis is only beginning to be
characterized (6, 11, 24), the Vegf signaling pathway is essen-
tial. Indeed, the vascular defect in Yap/ yolk sac (Fig. 5 and
6) appears similar to the yolk sac phenotype of embryos that
lack VEGFR1 (15) in which an overabundance of yolk sac
endothelial cells underlies vasculogenesis failure (16). Al-
though we have observed by RT-PCR retained expression of
VEGFA, VEGFR1, and VEGFR2 in Yap/ embryos (data
not shown), further study may support a role for YAP along
this pathway. Thus, we can now add YAP to the short list of
genes known to be required for yolk sac vasculogenesis and can
look for a potential role for YAP in the regulation of endo-
thelial cell number. Strikingly, the Yap/ embryo also pro-
allantoic bud (*) and yolk sac mesoderm (ysm), organized into early blood islands adjacent to yolk sac visceral endoderm (ve). Homozygous mutant
embryos at E7.5 (A and B) showed a developed chorion (#) but also variable developmental perturbations that included a pronounced
constriction at the embryonic-extraembryonic boundary (large arrows) and disorganized yolk sac mesoderm (small arrow; B). Sections at E8.5
(C to H) show proper tissue-specific development of amnion (C and C, arrowhead), chorion (C and C, #), neurectoderm (D and D), somites
(E and E), heart (F and F), and allantois (G and G) in both wild-type and homozygous mutant embryos. Compared to wild-type embryos, mutant
embryos showed abnormal development of posterior epiblast (C and C, small arrowhead to arrow), excessive folds of neurectoderm extending into
the amniotic cavity (D and D) and poorly defined blood islands in the yolk sac (H and H). bi, blood island; ht, heart; s, somite; ne, neurectoderm.
Scale bar: 240 m (C and C), 120 m (A, A, D, and D), 60 m (E, E, G, and G), and 30 m (B, B, F, F, H, and H).
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vides a genetic dissection of the process of vasculogenesis by
region: in yolk sac versus in both the embryo proper and the
allantois. This regional distinction corresponds largely, albeit
not strictly (11), with a cellular contingent difference. In yolk
sac, blood vessels develop adjacent to a visceral endoderm cell
layer and, in some regions, in association with blood cell pre-
cursors. In contrast, in both embryo (11) and allantois (10)
vasculogenesis proceeds largely in the absence of these other
cell types. Cell-cell interactions between yolk sac mesenchyme
and visceral endoderm appear to be important for yolk sac
vascular development (2, 13, 46). Therefore, it may be that the
role of YAP lies in the cross talk between yolk sac mesenchyme
and adjacent yolk sac visceral endoderm. Alternatively, YAP
may mediate steps essential for vessel development specifically
FIG. 6. Analysis of early endothelial and erythroblast markers in Yaptm1Smil homozygous mutant embryos. Whole-mount immunohistochemical
marking of PECAM1 protein (A to F) and in situ visualization of alpha globin expression (G to K). Endothelial cells marked by the PECAM1
antigen were present in both wild-type (A to C) and homozygous mutant (D to F) embryos late in the eighth day of development. Flat-mount
images show endothelial cells organized into a primitive vascular plexus in wild-type (A) but not mutant (D) yolk sacs, where instead they showed
an abundant but disordered distribution. In contrast, endothelial cells formed blood vessels in both the allantois (B and E) and the embryo proper
(C and F) in both wild-type and mutant embryos. Erythroblasts expressing alpha globin were present in the yolk sac region of both wild-type (G and
H) and homozygous mutant (I to K) embryos in the eighth day of development. In contrast to the organized early yolk sac ring of expression (G) or
later intravessel distribution (H) of erythroblasts in wild-type embryos, alpha globin-expressing cells in mutant embryos were abundant but
disordered (I to K). A higher magnification image of yolk sac is shown above each embryo image in G through K. Scale bar: 40 m (A, B, D, E),
160 m (C), 80 m (F), and 250 and 100 m (lower and upper, respectively [G to K]).
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in the presence of hematopoietic precursors, a developmental
process that remains largely uncharacterized.
YAP also appears fundamental to an early step in placental
development: attachment of the allantois to the chorion. The
bulbous appearance of the Yap/ allantois by E9.5 (Fig. 4I) is
like that observed in other embryos in which the allantois
forms and elongates but fails to fuse with the chorion (20, 28,
33, 34, 36, 42, 44, 48, 50, 52, 56, 59, 63, 67). We found that Yap
is expressed in the cell components potentially involved in the
process (9) including chorionic ectoderm, chorionic mesoderm,
and allantois (Fig. 2E, F, and H). In addition, we observed proper
initial development of these tissue types in mutant embryos, sug-
gesting again that YAP functions not generally for cell type spec-
ification but principally in the cell-cell interaction events required
for attachment. The apparent higher intensity Yap expression in
distal-tip allantois (Fig. 2H)—the very region required for initial
attachment—motivates further study. Curiously, for many of the
genes with identified roles in chorioallantoic attachment and fu-
sion, mutation causes defects in this process in only a fraction of
the homozygous mutant embryos. This observation supports the
existence of multiple pathways to reach fusion, each of which may
sometimes suffice alone. Remarkably, we found failed cho-
rioallantoic attachment in 100% of Yap/ embryos observed.
Therefore, YAP appears fundamental to this critical step in the
initiation of the placental circulation.
YAP plays a role in shaping the embryonic body axis. In
addition to showing critical requirements for YAP in early
steps of yolk sac vascular and placental development, Yap/
embryos also reveal an essential role for YAP in shaping the
main body axis of the embryo. Failure to elongate the body axis
in Yap/ embryos suggests a role for YAP in the regulation of
cell number in the embryo proper and/or in the fundamental
morphogenetic movements of gastrulation. We found that the
Yap/ embryo phenotype overall appeared remarkably simi-
lar to that shown by mouse embryos carrying mutations influ-
encing fibronectin (FN)-51 integrin interactions (17–19, 66,
68). Indeed, mouse embryos in which FN-51 interactions
have been perturbed show a short, wide body axis, and yolk sac
vascular defects as do Yap mutant embryos. Moreover, the
YAP binding partners of the Src kinase family have been
shown to mediate integrin-stimulated cell migration (41) and
mouse embryos triple mutant for three of these genes—Src,
c-Yes, and Fyn—also show a shortened body axis similar to the
FN-51 mutant classes (31) and thus also to Yap mutant
embryos. Furthermore, a possible role for YAP in the conver-
gent extension cell movements critical for vertebrate body axis
elongation is suggested by evidence of a role for the zebra fish
Fyn and c-Yes homologs in this process (29). Thus, YAP might
serve by several potential interactions to promote the morpho-
genetic movements critical for proper axis elongation.
In addition, YAP could impact axis elongation through the
regulation of proliferation, apoptosis, or both processes. In-
deed, YAP is known by biochemical and cell culture assays to
influence apoptotic and cell cycle regulatory pathways (12, 55).
Moreover, recent evidence from Drosophila supports a role for
YAP in regulating these processes (27). Nonetheless, the avail-
able genetic evidence from mice indicates that these known in-
teractions alone are insufficient to explain the phenotype since,
for example, mouse embryos homozygous mutant for either p73
(65) or p63 (40) survive to birth. Although not characterized
extensively in wild-type gastrula-stage mouse embryos, apoptosis
and proliferation appear to be fairly evenly distributed with po-
tentially higher rates of both processes associated with distal and
anterior epiblast (23, 38, 49, 51, 53, 54, 58). Although we are in the
process of rigorously examining both proliferation and apoptosis
in the absence of YAP, our histological preparations of E7.5
Yap/ embryos (Fig. 5A and B) do not suggest marked
changes in the number of mitotic or dying cells. At later stages,
with more perturbed mutant embryo development, it becomes
difficult to distinguish primary from secondary impacts on cell
survival and proliferation.
A critical developmental requirement for YAP is not com-
pensated for by TAZ expression. We observe expression of
both Yap and Taz throughout most of mouse embryo develop-
ment, with differential expression observed only at the blasto-
cyst stage (Fig. 1). Despite this predominantly concomitant
expression and our finding by RT-PCR analysis of retained Taz
expression in mutant embryos (data not shown), Yap/ em-
bryos show severe developmental perturbation. This result ar-
gues for critical requirements for YAP that cannot be com-
pensated for by potential redundant functions of the related
protein TAZ. Possibly, a single time window for this vital YAP
role occurs at peri-implantation stages, prior to TAZ expres-
FIG. 7. Whole-mount in situ analyses of Yap65tm1Smil homozygous
mutant embryos with postgastrulation markers of body axis development.
Anteroposterior pattern was revealed by restricted domains for Fgf8 (A to
C) at E9.5. Homozygous mutant embryos showed one or two stripes of
Fgf8 expression (B and C, arrows) consistent with the restricted neurec-
toderm expression domains in wild-type sibling embryos. The streak/
tailbud region is marked by both Fgf8 (A to C, asterisk) and Brachyury
(T; D to F, asterisk) in both wild-type (A and D) and homozygous mutant
(B, C, E, and F) embryos. Mutant embryos show an abnormally discon-
tinuous (E, arrows) and broad (F) Brachyury expression domain in mid-
line cells compared to wild-type embryos. Scale bar: 325 m (A to C, F to
H), 290 m (D), and 145 m (E).
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sion onset. Nonetheless, it seems likely that YAP plays many
roles throughout development some of which will occur during
concomitant TAZ expression. Thus, the phenotype of the mu-
tant embryo supports unique in vivo requirements for YAP.
Teasing apart the mechanisms of YAP function in develop-
ment may provide insight into the rules defining the indepen-
dent roles of these related proteins.
The study of YAP interactions and function in vitro and in
cell culture has identified several binding partners and poten-
tial signaling pathway interactions for this protein. We gener-
ated a targeted null allele to reveal YAP requirements at the
level of the whole organism. We found that the Yap/ phe-
notype overall is not easily accounted for by individual inter-
actions with known binding partners or signaling pathways.
This result may be explained to some extent by combinatorial
effects, with multiple YAP interactions impacting embryogen-
esis. These observations also may suggest, however, that pro-
tein-protein interactions between YAP and heretofore unrec-
ognized binding partners could play critical roles in the early
stages of embryogenesis.
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